Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ritiometan
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Intranasal, Topical
01
Overview
Ritiometan is a small molecule antibacterial agent primarily used in nasal sprays and aerosol preparations for the treatment of infections of the nose and throat, including viral rhinitis (the common cold) and rhinopharyngitis[1][2][3][4]. It is marketed in France under the trade name Nécyrane[1][3][4]. Chemically known as (methylidynetrithio)triacetic acid, ritiometan features three carboxylic acid groups and sulfur-containing moieties. Its antibacterial mechanism is not fully understood but may involve disruption of bacterial cell membranes or interference with essential metabolic pathways due to its thiol groups[6]. Ritiometan is administered topically via intranasal route.
- Brand names
- Nécyrane
- Other names
- methylidynetrithio triacetic acid2,2',2''-[methylidynetris(thio)]trisacetic acid2-[bis(carboxymethylsulfanyl)methylsulfanyl]acetic acid
Beyond the preview
Go deeper on ritiometan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ritiometan.